Quick access to up-to-date company information.
Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013
Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
For U.S. Media Only
Transition to Propellant-Free Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray Nears Completion
ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
DRIVE4COPD is a national public health campaign that aims to find the "missing millions" of people who may have Chronic Obstrusive Pulmonary Disease (COPD) and don't even know it.
900 Ridgebury Rd.P.O. Box 368Ridgefield, CT 06877